Phase 3 trials needed to determine efficacy of UBI's vaccine: experts
06/28/2021 05:13 PM
Taipei, June 28 (CNA) Experts in Taiwan said Monday that the results of the clinical trials conducted so far by United Biomedical Inc. (UBI) for its COVID-19 vaccine candidate have shown inconclusive results regarding its efficacy and that it requires further trials.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Bongkrek acid suspected in deadly Taipei food poisoning outbreak
03/28/2024 02:42 PM - Business
Taiwan's economy remains stable on improving exports, production
03/28/2024 02:27 PM - Business
Taiwan shares close down 0.27%
03/28/2024 02:06 PM - Society
Man arrested after firing shots inside lobby of Digital Ministry
03/28/2024 12:40 PM - Politics
Congressmen's Taiwan visit part of larger visit to Indo-Pacific: AIT
03/28/2024 11:37 AM